Therefore, we aimed to conduct a comprehensive analysis of the co-expression patterns of PD1, LAG3, TIGIT, and TIM3, their prognostic significance, and their association with tumor transcriptomics in patients with advanced lung adenocarcinoma undergoing treatment with PD1/PD-L1 inhibitors. Here, HAVCR2 is linked to lung adenocarcinoma.